Mammography World Markets

7.1 Global Market for Mammography Equipment 113

7.1.1 Global Market for Full-Field Digital Mammography Systems 114

7.1.2 Leading Vendors in Mammography Sector 115

7.2 U.S. Market for Full-Field Digital Mammography 115

7.2.1 Decline in the Number of Mammography Facilities and Units in the U.S. 116

7.2.2 Growth in Number of Digital Mammography Facilities in the U.S. 117

7.3 Rest of the World Market for Digital Mammography 118

7.4 Mammography Systems Market in Europe 119

8. Profiles of Market Leaders in Mammography 1218.1 Fujifilm U.S.A., Inc. 1218.1.1 Amulet f/Amulet s 1218.1.2 Fuji's 3D Mammography Viewer 1218.2 GE Healthcare Ltd. 1228.2.1 SenoBright 1228.2.2 Senographe Essential 1228.2.3 Senographe Essential e 1238.2.4 Senographe Care 1238.2.5 Senographe DS 1248.2.6 GE's Mammography Workstations 1248.3 Hologic, Inc. 1248.3.1 Selenia Dimension 3D 1258.3.2 Selenia Dimensions 2D 1258.3.3 SecurView 1268.3.4 SecurXchange Archiving Solution 1268.3.5 M-Series (Analog) 1268.3.5.1 StereoLoc 1268.3.5.2 Affinity 1278.4 Philips Healthcare 1278.4.1 MammoDiagnost (Analog) 1278.4.2 MammDiagnost DR 1288.4.3 MammoDiagnost with PCR Eleva 1288.5 Siemens Healthcare 1288.5.1 Mammomat 3000 Nova 1298.5.2 Mammomat 1000 1298.5.3 Syngo MammoReport 129

Appendix 1: Timeline of Advances Against Breast Cancer 130

Appendix 1.1: Timeline 130

Appendix 2: A Woman's Guide to Breast Cancer 138

Appendix 2.1: Breast Biopsy 138

Appendix 2.2: Staging of Breast Cancer 139

Appendix 2.3: Treatment Options 141

Appendix 3: A Women's Guide to Mammograms 146

Appendix 4: A Voice against Screening Mammography 151

Appendix 5: Performance of Tomosynthesis in Different Breast Compositions and Lesion Types 153

Appendix 5.1: Improved Sensitivity 154

Appendix 5.2: Reduced Recall Rate 154

Appendix 5.3: Greater Performance Using Two-View Tomosynthesis 155

Appendix 5.4: Performance of Tomosynthesis in Different Breast Compositions and Lesion Types 155

Appendix 5.5: Performance in Calcifications, Masses and Distortions 155

Appendix 5.6: Performance in Invasive and Non-Invasive Breast Cancers 156

Appendix 5.7: Performance in Fatty and Dense Breasts 156

« First ‹ Previous 1 2 3 4 5 6 7 8 9 ... Next › Last »